Relmada Therapeutics
RLMD
RLMD
43 hedge funds and large institutions have $319M invested in Relmada Therapeutics in 2020 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
20% more capital invested
Capital invested by funds: $265M → $319M (+$54.1M)
14.83% more ownership
Funds ownership: 47.8% → 62.63% (+15%)
4% less funds holding
Funds holding: 45 → 43 (-2)
Holders
43
Holding in Top 10
3
Calls
$880K
Puts
$3K
Top Buyers
| 1 | +$46.4M | |
| 2 | +$24.9M | |
| 3 | +$13.5M | |
| 4 |
RI
RTW Investments
New York
|
+$12.9M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$9.67M |
Top Sellers
| 1 | -$5.34M | |
| 2 | -$5.05M | |
| 3 | -$390K | |
| 4 |
Squarepoint
New York
|
-$348K |
| 5 |
MA
MYDA Advisors
Woodmere,
New York
|
-$273K |